This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Medizinische Hochschule Hannover, Twincore, Zentrum Fur Experimentelle Und Klinische Infektionsforschung Gmbh. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Christine Laqmani-Goffinet: Innovator in Anti-Viral Research
Introduction
Christine Laqmani-Goffinet is a notable inventor based in Munich, Germany. She has made significant contributions to the field of anti-viral agents through her innovative research. Her work focuses on developing novel labyrinthopeptin derivatives that have the potential to treat various infectious diseases.
Latest Patents
Christine holds a patent for "Labyrinthopeptins as anti-viral agents." This invention relates to novel labyrinthopeptin derivatives that are useful for treating infectious diseases caused by viruses such as human respiratory syncytial virus (RSV), Kaposi sarcoma-associated herpesvirus (KSHV), cytomegalovirus (CMV), dengue virus (DENV), chikungunya virus (CHIKV), tick-borne encephalitis virus (TBEV), vesicular stomatitis Indiana virus (VSV), zika virus (ZIKV), and hepatitis C virus (HCV). The labyrinthopeptin derivatives are also valuable for analyzing the mode of action of labyrinthopeptins. Furthermore, the invention includes a combination of labyrinthopeptin A1 and A2 for use as a medicament in treating infectious diseases.
Career Highlights
Christine has worked with prominent research institutions, including Helmholtz Zentrum für Infektionsforschung GmbH and Medizinische Hochschule Hannover. Her career reflects a strong commitment to advancing medical research and developing effective treatments for viral infections.
Collaborations
Christine has collaborated with esteemed colleagues such as Mark Brönstrup and Hans-Peter Prochnow. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Christine Laqmani-Goffinet is a pioneering inventor whose work in anti-viral research is making a significant impact in the medical field. Her dedication to developing effective treatments for infectious diseases showcases her valuable contributions to science and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile